MLEC
Moolec Science SA (NASDAQ)
Healthcare — Biotechnology
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
None
$7.73
+$0.26 (+3.49%)
Sign in to add MLEC to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $5.61M |
| P/E Ratio (TTM) | - |
| Forward P/E | -32.21 |
| EPS (TTM) | $-199.02 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 57.4 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $100.20 |
| 52-Week Low | $3.08 |
| 50-Day Avg | $8.01 |
| 200-Day Avg | $8.71 |
| Avg Volume | 263.2K |
| Volume | 6.0K |
Performance Analysis
NEUTRALMLEC presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($3.08), which could present a value opportunity.
+
RSI at 57.4 shows positive momentum.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:20 UTC
Back to Screener Export Report